Human papillomavirus and the risk of cervical cancer

Hospital Practice

Volumn 34, Issue 12, 1999, Pages 103-111

  Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; NEUTRALIZING ANTIBODY; ONCOPROTEIN; VACCINE; VIRUS DNA;

ARTICLE; CANCER RISK; CLINICAL TRIAL; CRYOTHERAPY; ELECTROSURGERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SOUTHERN BLOTTING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS GENOME; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS;

EID: 0033571440     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.1999.11.174     Document Type: Article

References (7)

1. Bosch FX et al: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective, International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796, 1995
2. Burk RD et al: Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 174:679, 1996
3. Ho GYF et al: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423, 1998
4. Lowy DR, Schiller JT: Papillomaviruses Prophylactic vaccine prospects. Biochim Biophys Acta 1423:M1, 1999
5. Palefsky JM et al: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 91:226, 1999
6. Schiller JT: Papillomavirus-like particle vaccines for cervical cancer Mol Med Today 5:209, 1999
7. Sun XW et al: Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 337:1343, 1997